SMTL ID : 3igg.1

Novel CDK-5 inhibitors - crystal structure of inhibitor EFQ with CDK-2

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x EFQ: N-[1-(cis-3-hydroxycyclobutyl)-1H-imidazol-4-yl]-2-(4-methoxyphenyl)acetamide(Non-covalent)

EFQ.1: 16 residues within 4Å: Chain A: E.9, I.11, V.19, A.32, K.34, F.81, E.82, F.83, L.84, H.85, Q.86, D.87, K.90, L.135, A.145, D.146 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:I.11, A:V.19, A:A.32, A:F.81, A:F.83, A:A.145 Hydrogen bonds: A:E.9, A:K.34, A:L.84, A:L.84

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Helal, C.J. et al., Potent and cellularly active 4-aminoimidazole inhibitors of cyclin-dependent kinase 5/p25 for the treatment of Alzheimer's disease. Bioorg.Med.Chem.Lett. (2009)

Release Date

2009-09-08

Peptides

Cell division protein kinase 2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Cell division protein kinase 2

Related Entries With Identical Sequence